Pharmabiz48m
Innate Pharma gets US FDA clearance to begin phase 1 study of Nectin-4 ADC, IPH4502 to treat solid tumours
Innate Pharma gets US FDA clearance to begin phase 1 study of Nectin-4 ADC, IPH4502 to treat solid tumours: Marseille, France Tuesday, September 24, 2024, 16:00 Hrs [IST] Innate P ...
Pharmabiz1h
Telix Pharma to acquire RLS to expand North American manufacturing and distribution platform
Telix Pharma to acquire RLS to expand North American manufacturing and distribution platform: Melbourne, Australia Tuesday, September 24, 2024, 15:00 Hrs [IST] Telix Pharmaceutica ...
Pharmabiz3h
Kerala IPA to honour four pharmacy professionals tomorrow as part of World Pharmacist Day celebration
Kerala IPA to honour four pharmacy professionals tomorrow as part of World Pharmacist Day celebration: Our Bureau, Chennai Tuesday, September 24, 2024, 13:30 Hrs [IST] The Kerala ...
Pharmabiz3h
Antengene receives Thailand FDA approval to commercialize Xpovio in Thailand
Antengene receives Thailand FDA approval to commercialize Xpovio in Thailand: Shanghai Tuesday, September 24, 2024, 13:00 Hrs [IST] Antengene Corporation Limited, a leading innova ...
Pharmabiz4h
US FDA approves anti-CD38 therapy, Sarclisa in combo with standard-of-care treatment for adult patients with NDMM who are not eligible for transplant
US FDA approves anti-CD38 therapy, Sarclisa in combo with standard-of-care treatment for adult patients with NDMM who are not eligible for transplant: Paris Tuesday, September 24, ...
Pharmabiz4h
Arya Vaidya Pharmacy in Coimbatore launches ‘Prachin Vriksha Ayurveda Chikitsa’ to rejuvenate trees
Arya Vaidya Pharmacy in Coimbatore launches ‘Prachin Vriksha Ayurveda Chikitsa’ to rejuvenate trees: Our Bureau, Chennai Tuesday, September 24, 2024, 12:15 Hrs [IST] The Arya ...
Pharmabiz5h
Teva Pharma announces long term efficacy and safety of deutetrabenazine in European patients with debilitating movement disorder tardive dyskinesia
Teva Pharma announces long term efficacy and safety of deutetrabenazine in European patients with debilitating movement disorder tardive dyskinesia: Tel Aviv, Israel Tuesday, Sept ...
Pharmabiz6h
Roche announces WHO included dual-stain cytology testing, CINtec PLUS in its cervical cancer prevention guideline
Roche announces WHO included dual-stain cytology testing, CINtec PLUS in its cervical cancer prevention guideline: Basel Tuesday, September 24, 2024, 10:00 Hrs [IST] Roche announc ...
Pharmabiz6h
API prices to remain weak for India in FY25, says Ind-Ra report
API prices to remain weak for India in FY25, says Ind-Ra report: Our Bureau, New Delhi Tuesday, September 24, 2024, 10:10 Hrs [IST] Active pharmaceutical ingredient (API) prices a ...
Pharmabiz2h
EU committee recommends approval of AstraZeneca’s Fasenra to treat eosinophilic granulomatosis with polyangiitis
AstraZeneca, global, science-led biopharmaceutical company, announced that its Fasenra (benralizumab) has been recommended for approval in the European Union (EU) as an add-on treatment for adult ...
Pharmabiz8h
Hyderabad to host landmark awareness programme on NABL accreditation for medical imaging facilities
Hyderabad to host landmark awareness programme on NABL accreditation for medical imaging facilities: Shardul Nautiyal, Mumbai ...
Pharmabiz8h
Biotech industry hopes new Vigyan Dhara of Rs. 10,000 crore to strengthen research and woo talent
The biotechnology industry hopes the new Vigyan Dhara initiative of the Union government with a Rs. 10,000 crore outlay will result in better fund utilisation, and improve efficiency with its support ...